Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mona M Saber"'
Publikováno v:
International Journal of Pharmaceutics: X, Vol 6, Iss , Pp 100215- (2023)
Metformin (MET), an oral antidiabetic drug, was reported to possess promising anticancer effects. We hypothesized that MET encapsulation in unique nanospanlastics would enhance its anticancer potential against HEP-2 cells. Our results showed the succ
Externí odkaz:
https://doaj.org/article/58f83445ab044d329374c262014e28e4
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background Colorectal cancer (CRC) remains a leading cause of death worldwide. Utilizing cisplatin in CRC is correlated with severe adverse effects and drug-resistance. Combined anticancer drug-treatment, along with, their enhanced delivery,
Externí odkaz:
https://doaj.org/article/07fa954e2aec49679f27757b49fb1a66
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 166:182-193
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in inflammatory bowel diseases (IBDs) are contradictory between their beneficial effect in alleviating inflammation, and injurious outcomes in aggravating the symptoms of colitis. The study ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0283258bd57dc771a2401ed0258dee77
https://doi.org/10.1016/j.ejpb.2021.06.009
https://doi.org/10.1016/j.ejpb.2021.06.009
Publikováno v:
2022 2nd International Mobile, Intelligent, and Ubiquitous Computing Conference (MIUCC).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ffb69b0ba8f7ea5bd88bb35c8576ff0
https://doi.org/10.1109/miucc55081.2022.9781727
https://doi.org/10.1109/miucc55081.2022.9781727
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 143, Iss, Pp 112140-(2021)
Acute lymphoblastic leukemia (ALL) is one of the most common type of leukemia in children. It is caused by abnormal cell division of the lymphoid progenitor cells in the bone marrow. In the past decade, metformin has gained increased attention for it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2602222c118f98e2da293bb369fa155e
http://www.sciencedirect.com/science/article/pii/S0753332221009240
http://www.sciencedirect.com/science/article/pii/S0753332221009240
Publikováno v:
Life Sciences. 306:120799
Acute kidney injury (AKI) is a sudden incident that is linked with a high lethality rate commonly due to distant organ injury. This study aims to explore the role of standardized Boswellia serrata (containing 35 % boswellic acid) in attenuating kidne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bdf8782fa53431aa4d44a64ee02a275
https://doi.org/10.1016/j.lfs.2022.120799
https://doi.org/10.1016/j.lfs.2022.120799
Publikováno v:
Life Sciences. 307:120874
The innate immune system is a primary protective line in our body. It confers its protection through different pattern recognition receptors (PRRs), especially toll like receptors (TLRs). Toll like receptor 9 (TLR9) is an intracellular TLR, expressed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd86b60ce3a16151e80fad7237a365a5
https://doi.org/10.1016/j.lfs.2022.120874
https://doi.org/10.1016/j.lfs.2022.120874
Publikováno v:
Life Sciences. 301:120594
Aim Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death worldwide. Systemic chemotherapy such as cisplatin and multi-targeted receptor tyrosine kinase inhibitors, including sunitinib, has marginal activity and frequent toxicit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61a2db4bd5913ed2daf2c2bf696369d1
https://doi.org/10.1016/j.lfs.2022.120594
https://doi.org/10.1016/j.lfs.2022.120594
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Background Colorectal cancer (CRC) remains a leading cause of death worldwide. Utilizing cisplatin in CRC is correlated with severe adverse effects and drug-resistance. Combined anticancer drug-treatment, along with, their enhanced delivery, can effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ef7764f02530e53f5f41436e34f0d3b
http://europepmc.org/articles/PMC6094476
http://europepmc.org/articles/PMC6094476
Publikováno v:
BMC Cancer
Background The link between inflammation and cancer has been confirmed by the use of anti-inflammatory therapies in cancer prevention and treatment. 5-aminosalicylic acid (5-ASA) was shown to decrease the growth and survival of colorectal cancer (CRC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::608c49a62bed277bfdbddd4991d9bc21